Suppr超能文献

曲尼司特对过敏反应迟缓反应物质(SRS-A)释放及平滑肌收缩的影响

[Effect of tranilast on the release of slow reacting substance of anaphylaxis (SRS-A) and contraction of the smooth muscle].

作者信息

Komatsu H, Ujiie A, Naito J

出版信息

Nihon Yakurigaku Zasshi. 1983 Jul;82(1):47-55.

PMID:6194082
Abstract

Slow reacting substance of anaphylaxis (SRS-A) and slow reacting substance (SRS) were released from actively sensitized guinea-pig lung with bovine serum albumin and from rat peritoneal exudate cells with ionophore A23187, respectively. FPL55712 markedly inhibited the contraction induced by SRS-A and SRS in guinea-pig ileum which was treated with atropine (10(-7) g/ml), mepyramine (10(-6) g/ml), and cyproheptadine (10(-7) g/ml). Tranilast and isoproterenol markedly suppressed the release of SRS-A in a dose-dependent manner; the concentrations of these drugs that gave 50% inhibition (IC50) were 1.1 X 10(-4)M and 8.3 X 10(-9)M, respectively. Although the inhibitory effect of tranilast (10(-3)M) was not affected in the presence of propranolol (3 X 10(-6)M), the inhibitory effect of isoproterenol was greatly diminished by propranolol. Also, tranilast markedly suppressed the release of SRS in a dose-dependent manner, its IC50 being 6.4 X 10(-5)M. However isoproterenol slightly inhibited the release of SRS. Disodium cromoglycate did not suppressed the release of SRS-A at all, and it suppressed SRS release a little. Tranilast inhibited the contraction induced by leukotriene C4 (0.5 ng/ml) and D4 (1 ng/ml) in guinea-pig trachea in a dose-dependent manner; the IC50 values were 2.2 X 10(-4)M and 2.0 X 10(-4)M, respectively, for these inhibitions. These results suggest that the inhibition of SRS-A release and SRS-A-induced contraction of smooth muscle by tranilast participates in the anti-asthmatic effect of tranilast, and its inhibitory mechanism is different from that of isoproterenol.

摘要

过敏反应慢反应物质(SRS-A)和慢反应物质(SRS)分别从用牛血清白蛋白主动致敏的豚鼠肺以及用离子载体A23187处理的大鼠腹腔渗出细胞中释放出来。FPL55712显著抑制了用阿托品(10^(-7) g/ml)、美吡拉敏(10^(-6) g/ml)和赛庚啶(10^(-7) g/ml)处理的豚鼠回肠中由SRS-A和SRS诱导的收缩。曲尼司特和异丙肾上腺素以剂量依赖性方式显著抑制SRS-A的释放;产生50%抑制作用(IC50)的这些药物浓度分别为1.1×10^(-4)M和8.3×10^(-9)M。尽管在普萘洛尔(3×10^(-6)M)存在的情况下曲尼司特(10^(-3)M)的抑制作用不受影响,但异丙肾上腺素的抑制作用被普萘洛尔大大减弱。此外,曲尼司特以剂量依赖性方式显著抑制SRS的释放,其IC50为6.4×10^(-5)M。然而异丙肾上腺素对SRS的释放略有抑制。色甘酸钠根本不抑制SRS-A的释放,对SRS释放有轻微抑制作用。曲尼司特以剂量依赖性方式抑制豚鼠气管中白三烯C4(0.5 ng/ml)和D4(1 ng/ml)诱导的收缩;这些抑制作用的IC50值分别为2.2×10^(-4)M和2.0×10^(-4)M。这些结果表明,曲尼司特对SRS-A释放的抑制作用以及对SRS-A诱导的平滑肌收缩的抑制作用参与了曲尼司特的抗哮喘作用,并且其抑制机制与异丙肾上腺素不同。

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验